MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MH-17-0000615
Rennacle Pharmaceutical Private Limited
Rennacle Pharmaceutical Private Limited - pharma in Nsp Nala Sopara, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹5.64 Lakh
▲ 138% YoY
Net loss · FY 2024
₹20,400
Net margin -3.6%
EBITDA · FY 2024
-₹20,400
EBITDA margin -3.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Rennacle Pharmaceutical Private Limited
Data last updated:
Rennacle Pharmaceutical Private Limited is a private limited company based in Nsp Nala Sopara, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85100MH2019PTC319693.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Dimpal Devi and Avinash Kumar Dixit.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No 909 Raj Heights Yashwant Gaurav Marg, Nsp Nala Sopara, Maharashtra, India – 401203.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.64 Lakh, a growth of 138% compared to the previous year. For the same year it recorded a net loss of ₹20,400 (net margin -3.6%) and EBITDA of -₹20,400 (EBITDA margin -3.6%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years.
Rennacle Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0000615). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U85100MH2019PTC319693
Registration Number 319693
Incorporation Date 16 January 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-17-0000615
Key People
Dimpal Devi Director Avinash Kumar Dixit Director Recognitions & Rankings of Rennacle Pharmaceutical
Contact details
Rennacle Pharmaceutical Private Limited's registered office is in Nsp Nala Sopara, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No 909 Raj Heights Yashwant Gaurav Marg, Nsp Nala Sopara, Maharashtra, India – 401203
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Rennacle Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Rennacle Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Rennacle Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Rennacle Pharmaceutical Private Limited, buy the company report.
Financials of Rennacle Pharmaceutical Private Limited
FY 2025 filings availableRennacle Pharmaceutical Private Limited reported revenue of ₹5.64 Lakh (up 138% YoY) for FY 2024.
Revenue · FY 2024
₹5.64 Lakh ▲ 138%
Net loss · FY 2024
₹20,400 margin -3.6%
EBITDA · FY 2024
-₹20,400 margin -3.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 138%
3 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▲ 78%
3 years · compounded
▼ 34%
Revenue has grown at a compounded annual rate (CAGR) of 15% over three years, including 138% growth in the latest year. EBITDA rose 78% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹20,400 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹20,400 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3.6% | ||||
| Net Profit Margin | -3.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rennacle Pharmaceutical Private Limited, buy the company report.
Board of directors of Rennacle Pharmaceutical Private Limited
Rennacle Pharmaceutical has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dimpal Devi | Director | 16 Jan 2019 | 7 Years 9 Months | Current |
| Avinash Kumar Dixit | Director | 16 Jan 2019 | 7 Years 9 Months | Current |
Peer comparison
Rennacle Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Greenmax Trading Private Limited | ₹5.65 Lakh (FY 2025) | -93.0% | New Delhi, Delhi, India | |||
| Padme Infradevelopers Private Limited | ₹5.65 Lakh (FY 2025) | -86.0% | Mumbai, Maharashtra, India | |||
| Sebjon Chai Bar Private Limited | ₹5.65 Lakh (FY 2025) | 19.0% | Jaipur, Rajasthan, India | |||
| Abuor Nexus Private Limited | ₹5.65 Lakh (FY 2025) | 1005.0% | Mumbai, Maharashtra, India | |||
| Sidheshwar Trading and Finance Ltd | ₹5.65 Lakh (FY 2025) | 8.0% | Mumbai, Maharashtra, India | |||
| Rennacle Pharmaceutical Private Limitedthis company | ₹5.64 Lakh (FY 2024) | -₹20,400 | -3.6% | 138.0% | Nsp Nala Sopara, Maharashtra, India | |
| Glenzo Healthcare Private Limited | ₹5.63 Lakh (FY 2025) | 76.0% | Abbigere, Karnataka, India | |||
| Thanmull Import & Export (India) Private Limited | ₹5.63 Lakh (FY 2025) | 15.0% | Kolkata, West Bengal, India | |||
| Veldis Sales Limited | ₹5.62 Lakh (FY 2025) | -45.0% | Mumbai, Maharashtra, India | |||
| Diyas Mantra Lighting Private Limited | ₹5.62 Lakh (FY 2024) | 99.0% | New Delhi, Delhi, India | |||
| JN Agro Exports Private Limited | ₹5.61 Lakh (FY 2025) | -99.0% | Ferozepur, Punjab, India |
To see the full peer comparison of Rennacle Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rennacle Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rennacle Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rennacle Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rennacle Pharmaceutical Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Avinash Kumar Dixit was appointed as Director on 16 Jan 2019.
AGM
Rennacle Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rennacle Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Avinash Kumar Dixit was appointed as Director.
Appointed
Dimpal Devi was appointed as Director.
Incorporation
16 Jan 2019
Rennacle Pharmaceutical Private Limited was registered on 16 Jan 2019 with Roc Mumbai & aged 7 years 9 months as per MCA records.
Frequently asked questions
Rennacle Pharmaceutical is an active private limited company based in Nsp Nala Sopara, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 January 2019 (7+ years old) and is registered under CIN U85100MH2019PTC319693.
Rennacle Pharmaceutical has 2 current directors:
- Dimpal Devi - Director
- Avinash Kumar Dixit - Director
The latest financial statements of Rennacle Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Rennacle Pharmaceutical is U85100MH2019PTC319693. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rennacle Pharmaceutical was incorporated on 16 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Rennacle Pharmaceutical by revenue are Greenmax Trading Private Limited, Padme Infradevelopers Private Limited, Sebjon Chai Bar Private Limited, Abuor Nexus Private Limited, Sidheshwar Trading and Finance Ltd and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Avinash Kumar Dixit was appointed as Director on 16 Jan 2019. Dimpal Devi was appointed as Director on 16 Jan 2019.
Yes, Rennacle Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-17-0000615).
The registered office of Rennacle Pharmaceutical is at Flat No 909 Raj Heights Yashwant Gaurav Marg, Nsp Nala Sopara, Maharashtra, India – 401203.
Rennacle Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Rennacle Pharmaceutical is compliant as of 14 September 2026. The company is actively filing with the Registrar of Companies.